These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 26411831
1. Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis. Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y. Sci Rep; 2015 Sep 28; 5():14517. PubMed ID: 26411831 [Abstract] [Full Text] [Related]
6. Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD). Mohamad NA, Ramachandran V, Ismail P, Mohd Isa H, Chan YM, Ngah NF, Md Bakri N, Ching SM, Hoo FK, Wan Sulaiman WA, Inche Mat LN, Hazmi Mohamed M. Bosn J Basic Med Sci; 2018 Aug 01; 18(3):260-267. PubMed ID: 29579408 [Abstract] [Full Text] [Related]
7. Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration. Feng X, Xiao J, Longville B, Tan AX, Wu XN, Cooper MN, McAllister IL, Isaacs T, Palmer LJ, Constable IJ. Ophthalmology; 2009 Oct 01; 116(10):1908-12.e1. PubMed ID: 19692124 [Abstract] [Full Text] [Related]
9. [The pharmacogenomics of CFH Y402H and wet age-related macular degeneration]. Chen LL, Chen YY. Zhonghua Yan Ke Za Zhi; 2017 Feb 11; 53(2):144-147. PubMed ID: 28260367 [Abstract] [Full Text] [Related]
10. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population. Medina FMC, Motta AALD, Takahashi WY, Carricondo PC, Motta MMDS, Melo MB, Vasconcellos JPC. Ophthalmic Res; 2019 Feb 11; 61(3):168-173. PubMed ID: 28641277 [Abstract] [Full Text] [Related]
11. Association of ARMS2/LOC387715 A69S, CFH Y402H, and CFH I62V polymorphisms with retinal angiomatous proliferation compared with typical age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH, Yaseri M, Bonyadi M, Soheilian M. Int Ophthalmol; 2017 Dec 11; 37(6):1397-1409. PubMed ID: 28005184 [Abstract] [Full Text] [Related]
12. Comparison of ARMS2/LOC387715 A69S and CFH Y402H risk effect in wet-type age-related macular degeneration: a meta-analysis. Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Nazari R, Soheilian M. Int Ophthalmol; 2019 Apr 11; 39(4):949-956. PubMed ID: 29423786 [Abstract] [Full Text] [Related]
13. Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography. Teper SJ, Nowinska A, Pilat J, Wylegala E. Photodiagnosis Photodyn Ther; 2016 Mar 11; 13():108-113. PubMed ID: 26780119 [Abstract] [Full Text] [Related]
14. Association of risk genotypes of ARMS2/LOC387715 A69S and CFH Y402H with age-related macular degeneration with and without reticular pseudodrusen: a meta-analysis. Jabbarpoor Bonyadi MH, Yaseri M, Nikkhah H, Bonyadi M, Soheilian M. Acta Ophthalmol; 2018 Mar 11; 96(2):e105-e110. PubMed ID: 28593728 [Abstract] [Full Text] [Related]
18. An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, Lotery AJ. Eye (Lond); 2008 Jun 11; 22(6):849-54. PubMed ID: 17464302 [Abstract] [Full Text] [Related]
19. Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, Magnusson K, Zhang K, Attia J. Hum Mol Genet; 2006 Sep 15; 15(18):2784-90. PubMed ID: 16905558 [Abstract] [Full Text] [Related]